Trace Wealth Advisors’s Sana Biotechnology SANA Stock Holding History

Trace Wealth Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.1K	Buy	+16,000	New	+$63K	0.03%	66

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Trace Wealth Advisors's SANA Position: Q1 2026 in Review

Trace Wealth Advisors opened a new position in Sana Biotechnology (SANA) in Q1 2026: 16,000 shares worth $46.1K. The stake represents 0.03% of the portfolio and ranks #66 among its holdings.

202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Trace Wealth Advisors held 16,000 shares of Sana Biotechnology worth $46.1K as of Q1 2026.
Sana Biotechnology was a new Trace Wealth Advisors position in Q1 2026.
Sana Biotechnology made up 0.03% of Trace Wealth Advisors's portfolio in Q1 2026, its #66 holding.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Trace Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.